Development and validation of a prognostic gene-expression signature for lung adenocarcinoma
about
Lung Cancer Gene Signatures and Clinical PerspectivesGenetic basis for clinical response to CTLA-4 blockade in melanomaSPARCoC: a new framework for molecular pattern discovery and cancer gene identificationBig data and computational biology strategy for personalized prognosis.Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcomeValidation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaMolecular gene signature and prognosis of non-small cell lung cancer.Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma.Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm.Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.eMBI: Boosting Gene Expression-based Clustering for Cancer Subtypes.Robust method for identification of prognostic gene signatures from gene expression profiles.Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection.Intrinsic cancer subtypes-next steps into personalized medicine
P2860
Q28387769-CFBCBB03-4DDC-4FC7-BDD7-00EAAD105E54Q29620594-9F8E7350-ACC2-4058-986A-A93737BC0569Q35175659-37988AC9-EFC9-4669-B195-0FAFB5856511Q36031260-DD9307A4-1969-4C27-AF10-FB74A099B914Q36833446-ACF135BD-0825-4FCB-ACC6-6CA790045647Q37325311-3A92A069-4974-4EF0-9684-C38F6F00DEDDQ37588387-54980EFF-9BA6-45E4-8291-BB3E3397F0DBQ37619692-2B86CA1E-8AE0-435C-B904-E1A009288E6DQ40629175-A758BC25-C0D2-4B76-81C1-E11193DF2539Q41557019-A89C557C-FA1F-4E38-B59D-FB4ED7D73ACBQ41878464-95219728-43F0-4EEC-9451-A6453151F10AQ42967077-438FC212-4734-440D-8123-191C44EFDE79Q47103384-B6E57A6B-6288-4EB1-B126-E53A95B34803Q47130427-8E7050A4-0557-4E0B-BE47-1DFCD5994BA5Q58053534-ED4827E4-6C4C-494F-B256-B6AF110A480D
P2860
Development and validation of a prognostic gene-expression signature for lung adenocarcinoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Development and validation of ...... nature for lung adenocarcinoma
@ast
Development and validation of ...... nature for lung adenocarcinoma
@en
Development and validation of ...... nature for lung adenocarcinoma
@nl
type
label
Development and validation of ...... nature for lung adenocarcinoma
@ast
Development and validation of ...... nature for lung adenocarcinoma
@en
Development and validation of ...... nature for lung adenocarcinoma
@nl
prefLabel
Development and validation of ...... nature for lung adenocarcinoma
@ast
Development and validation of ...... nature for lung adenocarcinoma
@en
Development and validation of ...... nature for lung adenocarcinoma
@nl
P2093
P2860
P1433
P1476
Development and validation of ...... nature for lung adenocarcinoma
@en
P2093
Bo Hwa Sohn
Eun Sung Park
Gordon B Mills
In-Sun Chu
Ju-Seog Lee
Lauren Averett Byers
Sang Bae Kim
Sang Cheol Kim
Woojin Jeong
Yun-Yong Park
P2860
P304
P356
10.1371/JOURNAL.PONE.0044225
P407
P577
2012-09-07T00:00:00Z